Briefings on JHS, CHS, KHS and THS guidelines and their difference from JNC VII and ESC/ESH

International Journal of Clinical Practice

Volumn 60, Issue SUPPL. 150, 2006, Pages 3-6

  Fujita, T ^a   Wu, Z ^b   Park, J B ^c   Chen, M F ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Asia; China; Guidelines; Hypertension; Japan; Korea; Taiwan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LONG ACTING DRUG; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; CHINA; CLINICAL PRACTICE; CONSENSUS; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG POTENTIATION; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; KOREA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; TAIWAN;

EID: 33748948584     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01115.x     Document Type: Article

References (8)

1. Zhou BF, Stamler J, Dennis B et.al., Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: The INTERMAP study. J Hum Hypertens 2003; 17: 623-630.
2. Liu J, Hong Y, D'Agostino RB et.al. Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared with the Chinese Population. Multi-provincial Cohort Study. JAMA 2004; 291: 2591-2599.
3. Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, with 64 other contributors for the WHO MONICA Project. Monica Monograph and Multimedia Source book. Hugh Tunstall-Pedoe (ed.) World Health Organization, Geneva, Switzerland, 2003.
4. Wu ZS, Yao C, Zhao D et.al. Cardiovascular disease risk factor levels and their relations to CVD rates in China -results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil 2004; 11: 275-83.
5. Greenlund KJ, Croft JB, Manesh GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164: 2113-8.
6. Wolf-Maier K, Cooper RS, Banegas JR et.al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-9.
7. Saruta T. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Nippon Rinsho. 2005; 63: 952-8.
8. Revision Committee of the Chinese guidelines on prevention and treatement of hypertension. Chinese guidelines on prevention and treatment of hypertension. Chin J Hypertens 2004; 12: 248-56.